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SUMMARY
Motor neurons (MNs) and astrocytes (ACs) are
implicated in the pathogenesis of amyotrophic
lateral sclerosis (ALS), but their interaction and the
sequence of molecular events leading to MN death
remain unresolved. Here, we optimized directed dif-
ferentiation of induced pluripotent stem cells (iPSCs)
into highly enriched (> 85%) functional populations of
spinal cord MNs and ACs. We identify significantly
increased cytoplasmic TDP-43 and ER stress as pri-
mary pathogenic events in patient-specific valosin-
containing protein (VCP)-mutant MNs, with second-
ary mitochondrial dysfunction and oxidative stress.
Cumulatively, these cellular stresses result in synap-
tic pathology and cell death in VCP-mutant MNs. We
additionally identify a cell-autonomous VCP-mutant
AC survival phenotype, which is not attributable to
the same molecular pathology occurring in VCP-
mutant MNs. Finally, through iterative co-culture ex-
periments, we uncover non-cell-autonomous effects
of VCP-mutant ACs on both control andmutant MNs.
This work elucidates molecular events and cellular
interplay that could guide future therapeutic strate-
gies in ALS.
INTRODUCTION
ALS (amyotrophic lateral sclerosis) is a rapidly progressive and
fatal neurological condition characterized by degeneration of
MNs (motor neurons). Over 20 distinct gene mutations have
been identified, although their collective functions have not yet
converged on a singular molecular pathway. Autosomal-domi-
nant VCPmutations account for 2% of familial ALS cases (John-
son et al., 2010), comparable to mutations in the TARDBP-gene-
encoding transactive-response DNA-binding protein, 43 kDa
(TDP-43) (Sreedharan et al., 2008). The VCP gene encodes
valosin-containing protein (VCP or p97), which is ubiquitously
expressed and contributes to myriad cellular functions in a
cofactor-dependent manner. VCP functions include mainte-
nance of protein homeostasis, mitochondrial quality control,
and apoptosis (Meyer et al., 2012). Wild-type TDP-43 mislocali-
zation and aggregation form the pathological hallmark in > 95%
of all ALS cases (Neumann et al., 2006), including VCP-related
ALS (Johnson et al., 2010).
While undeniably valuable both animal-based models and
many cell-based ones have thus far relied on VCP overexpres-
sion or knockdown in non-human or non-neuronal cells, which
may fail to precisely capture the clinical pathophysiological
state. Consequently, there is a need for accurate charac-
terization of how mutant VCP affects human MNs and ACs
(astrocytes). To examine early pathogenic events in VCP-
related ALS, we employed patient-specific iPSCs and robust
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ontogeny-recapitulating methods of directed differentiation to
enriched populations of both spinal cord MNs and ACs. By inte-
grating this human experimental platform with cellular phenotyp-
ing assays, we uncovered early sequential pathogenic events in
VCP-mutant MNs. Additionally, we identified VCP-mutant cell-
autonomous AC pathology and a non-cell-autonomous effect
of mutant ACs on both control and mutant MNs.
RESULTS
Generation of iPSCs, Spinal Cord MNs, and ACs
Using established reprogramming methods (Okita et al., 2011),
four clones of mutant iPSCs were generated from two pa-
tients with confirmed VCP mutations: R191Q (2 clones), R155C
(2 clones) (Ludtmann et al., 2017). Three healthy control iPSC
lines were used as comparators (details provided in Table S1).
We developed robust methods for generating highly enriched
cultures of both MNs and ACs in feeder-free, chemically defined
monolayer culture by adapting previously published protocols
(Figure 1A) (Chen et al., 2014). RNA sequencing (Figures 1B
and 1C), immunocytochemical (Figures 1D and 1E), and func-
tional assays (Figure 1F) were used to validate our directed dif-
ferentiation strategies. Neural conversion involved three small
molecule inhibitors of the activin/nodal, BMP4, and GSK3b path-
ways for 7 days, followed by patterning with retinoic acid (RA)
and a sonic hedgehog agonist (Purmorphamine) to generate spi-
nal-cord MN precursors, which expressed OLIG2 and HOXB4
(Figures 1A, 1B, 1C, 1Di, and 1Ei). Upon terminal differentiation,
these cultures yielded > 85% SMI32 and Choline acetyltransfer-
ase (ChAT) expressing MNs (Figures 1B, 1C, 1Dii, and 1Eii).
Ventral spinal interneurons (INs; including V2 and V3 subtypes)
only represented < 8%of our cultures by quantitative immunocy-
tochemisty (data not shown). At day 17 of terminal differentiation
(d17), whole-cell patch clamp demonstrated passive (n = 12) and
active properties (n = 16) of MNs. In all cases, current injection
evoked action potentials (rheobase 3.5 ± 0.5 pA) (Figure 1Fi).
Spontaneous firing was also observed. 15/16 cells fired repeti-
tively with increasing current injection. Action potentials were
tetrodotoxin (TTX) sensitive (n = 3) (Figure 1Fii). We assessed
the cytosolic calcium response to physiological calcium stimuli
(glutamate and KCl) to confirm the presence of glutamate recep-
tors and voltage-dependent calcium channels. 98% of d17 MNs
responded to KCl and glutamate stimulation, but not to ATP (Fig-
ure 1Fiii). For AC differentiation, MN precursors were maintained
in FGF2 forR 60 days, yielding a population of > 80% vimentin-
and > 90% NF1A-expressing gliogenic precursors (GPCs) (Fig-
ures 1A, 1B, 1C, 1Diii and 1Eiii). GPCs were terminally differenti-
ated in BMP4 and LIF, as previously described (Gupta et al.,
2012). Enriched populations of ACs expressing GLAST (gluta-
mate aspartate transporter) (> 90%) and GFAP (glial fibrillary
acidic protein) (> 70%) (Figure 1Div and 1Eiv) were functionally
validated by > 98% of cells demonstrating cytosolic calcium re-
sponses to ATP but not KCl (Figure 1Fiv).
VCP-Mutant Cultures Recapitulate Key Aspects of ALS
Pathogenesis
Impaired Cellular Viability of VCP-Mutant MNs
Percentage cell death was measured at three time points in MN
development (neural precursor cells [NPCs], d3 MNs, and d17
MNs), revealing a significant increase in the VCP-mutant d17
MNs compared to control (41.8% ± 5.8% versus 20.1% ±
2.8%, p < 0.05, unpaired t test; Figure 2Aii). This was confirmed
using an automated longitudinal imaging platform, cumulative
hazard ratio (cHR) of VCP-mutant MNs over control: 1.75,
p = 1.08 3 108, log-rank test (Figure 2B), as described previ-
ously (Barmada et al., 2010). Cell death was also assayed
by measuring cleaved caspase 3 (apoptosis) and nuclear
pyknosis, which were both significantly higher in VCP-
mutant MNs compared to control counterparts (9.3% ± 0.8%
versus 3.7% ± 1.4% cleaved caspase 3; 39.5% ± 3.3% versus
19.7% ± 5.4% pyknotic nuclei, p < 0.01, unpaired t test) (Fig-
ure 2Ci and 2Cii).
Synapse Formation Is Disrupted in VCP-Mutant MNs
We examined pre-synaptic puncta adjacent to soma or den-
drites of d17 MNs, which were analyzed in cell clusters intercon-
nected by axons forming a network. Pre-synaptic terminals and
MNs were identified by immunolabelling for the pre-synaptic
marker synaptotagmin-1 (SYT-1) and ChAT, respectively (Fig-
ure 2Di). A significant 2-fold reduction in the density of SYT-1
positive puncta on cell somata (0.052+0.003 puncta/mm2;
unpaired t test, ****p < 0.0001; Figure 2Dii left plot) and dendrites
(0.073+0.004 puncta/mm2; unpaired t test, ****p < 0.0001;
Figure 1. Enriched Motor Neurogenesis and Astrogliogenesis from iPSCs
(A) Schematic showing differentiation strategy for motor neurogenesis and astrogliogenesis.
(B) Heat map showing classic cell-type-specific gene expression from iPSC (technical n = 8, across 5 different cell lines), MN (technical n = 6, across 5 different
cell lines), and AC (technical n = 8, across 4 different cell lines) cellular populations. Points represent normalized RPKM values that are log2 transformed and
mean-centered.
(C) Representative normalized RPKM values of cell-type specific genes (**p < 1.0E-04 ****p < 1.0E-08). Transcripts that showed a log 2-fold differential expression
and a p value < 0.05, and that were reliably expressed in either VCP-mutant or control condition were considered as changing significantly. Error bars represent
mean ± SEM.
(D) Representative immunocytochemistry images of (Di) ventral spinal NPCs – Olig2 and HOXB4, (Dii) MNs – SMI32, ChAT, (Diii) GPCs – NF1A, vimentin (VIM) and
(Div) ACs – GLAST, GFAP.
(E) Quantitative immunocytochemistry of selected cellular markers for (Ei) ventral spinal NPCs – Olig2 and HOXB4 (Eii) MNs – SMI32, ChAT, (Eiii) GPCs – NF1A,
VIM and (Eiv) ACs – GLAST, GFAP.
(F) MNs generate TTX-sensitive action potentials (Fi) a representative trace recorded during current injection (1, 0, 1, 2, 3 pA) to evoke action potentials. (Fii)
Action potentials were blocked by TTX (5, 0, 5, 10, 15 pA steps). (Fiii) 98% of our MN cultures responded to KCl and glutamate stimulation, but not to ATP. (Fiv)
Enriched AC cultures were functionally validated by > 98% of the cultures demonstrating cytosolic calcium responses to ATP but not KCl. TTX = Tetrodotoxin.
iPSC = induced pluripotent stem cells, NPCs = neural precursors, MN = motor neurons (d3 or d17 = after 3 or 17 days of terminal differentiation), GPCs = glial
precursors, AC = astrocytes (d14 or d28 = after 14 or 28 days of terminal differentiation).
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Figure 2. VCP-Mutant Motor Neuron Cell Survival and Synaptic Phenotypes
(A) (Ai) Representative images of Hoechst (blue) and propidium iodide (PI; red) staining in control and VCP-mutant d17 MNs. (Aii) Quantification of percentage of
PI-positive cells in control and VCP-mutantMNs; n = 3 control lines and 4mutant lines for NPC, d3MN and d17MN; p < 0.05, unpaired t test;% cell death for each
line at each time was calculated from at least two independent inductions per line on separate days and with at least three replicate wells per induction per day. At
least 2,000 cells were counted for each well. Data represent mean ± SEM.
(B) Longitudinal imaging based survival analysis comparing VCP-mutant versus CTRL MNs. (Bi) Representative images showing a MN captured by longitudinal
imaging when alive (left panel) and dead (right panel).(Bii) VCP-mutant MNs present increased cumulative risk of death under basal conditions (cumulative hazard
ratio [cHR] = 1.75, p = 1.083 108; CTRL MNs taken as baseline). N = 3 control lines and 3 VCP-mutant lines. To estimate survival Kaplan–Meier and cumulative
risk-of-death curves were plotted using R, while Cox proportional hazards analysis, also calculated in R, was used to determine the influence of the VCPmutation
(legend continued on next page)
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Figure 2Dii right plot) was found in VCP-mutant cultures
compared to control (0.104+0.006 puncta/mm2 and
0.139+0.007 puncta/mm2, respectively). To further confirm a
synaptic phenotype we co-immunolabeledMNs for pre-synaptic
(SYT-1) and post-synaptic (Homer-1) markers and analyzed their
juxtaposition with proximity measurements. Significant reduc-
tions in synaptic density at the soma (0.036+0.004 puncta/
mm2; unpaired t test, ***p < 0.001) and dendrites (0.033+0.004
puncta/mm2; unpaired t test, ****p < 0.0001; Figure 2Eii) were
confirmed in VCP-mutant MNs compared to control MNs
(0.066+0.006 and 0.083+0.007 puncta/mm2, respectively). To
determine whether synapse loss represented early MN dysfunc-
tion or loss of interconnected MNs/Ins, we counted the number
of ChAT/MAP-2 positive neurons with intact DAPI-stained nuclei
in the analyzed cell clusters. Both the number of total neurons
and the MN:IN ratios were comparable between the two exper-
imental conditions, indicating that synapse loss in VCP-mutant
MNs is not attributable to differential loss of MNs or INs
(data not shown). Furthermore, synaptic perturbation was also
revealed by transcriptional profiling of SLITRK4, SLITRK2,
CBLN2, NLGN4Y, PTPN5, and ACHE, which are relevant to syn-
apse structure and assembly (Figure S1A). Analysis of an array of
different ion channels revealed further transcriptional deregula-
tion, specifically in the delayed rectifier potassium channel,
KCNA2; the inward rectifier potassium channel, KCNJ5; the
sodium channel, SCN2A; and glutamate receptors, GRIN2A
and GRM7 (Figure S1B).
Having identified cell death, synapse loss, and transcriptional
perturbations of genes encoding ion channels and synapse
structure and/or assembly, we next addressed VCP mutation-
related functional consequences by examining electrophysio-
logical properties of our MNs on multi-electrode arrays (MEAs).
Electrical activity began to appear on individual electrodes dur-
ing the first few days following differentiation as random spiking.
Over subsequent maturation of control MNs, uncoordinated
local bursting behavior was observed on active electrodes that
eventually became synchronized across the whole active
network (Figure S2). These periods of high synchrony occurred
at very low frequency, with an interval of 60–100 s. Within these
periods of synchrony, a pattern of burst firing occurred that oscil-
lated at a frequency of around 0.5 Hz with diminishing activity as
the bursting period proceeded. VCP-mutant MNs showed an
electrophysiological phenotype of an overall decrease in activity
and bursting behavior, which temporally coincides with our
viability and synaptic phenotypes. Furthermore, the level of func-
tional coordination across the cell network, which resulted in the
appearance of array-wide synchronized bursts, appeared to be
impaired in VCP-mutant MNs (Figure S2).
Increased Cytoplasmic TDP-43 and ER Stress Are Early
Events in VCP-Mutant MNs
Mislocalization of TDP-43 from the nucleus to cytoplasm corre-
lates with cellular toxicity (Barmada et al., 2010). To explore this
known pathological hallmark of ALS in our model, we examined
cytoplasmic TDP-43 during MN differentiation. NPCs revealed
no significant differencebetween control andVCP-mutant condi-
tions (Figure 3Ai and 3Aii). However, the percentage of cytosolic
TDP-43 was significantly increased in VCP-mutant d3 MNs
compared to control (46.0% ± 3.4% versus 29.1% ± 2.3%
p < 0.05, unpaired t test; Figure 3Ai and3Aii). We reasoned that
increased cytoplasmic TDP-43 may be linked to ER stress. We
detected significantly increased expression of BiP (p < 0.01 at
d3; p < 0.05 at d17) and p-eIF2alpha (p < 0.05 at d17) in the
VCP-mutantMNs (Figure 3Bi and 3Bii).We examined ER calcium
stores and found significant reduction in VCP-mutant d3 MNs
(63.7% ± 2.4% of control, p < 0.05, unpaired t test; Figure 3C).
A 48 hr tunicamycin ER stress assay also revealed significantly
increased cell death in VCP-mutant d3MNs compared to control
(43.3% ± 2.7% versus 79.2% ± 5.2%, p < 0.05, unpaired t test;
Figure 3D). Noting that ER stress is associated with altered
contact between ER and mitochondria, we quantified mitochon-
drial-ER contacts using an electron microscopy (EM) approach
(Schneeberger et al., 2013), which confirmed a significant
increase in the VCP-mutant d17 MNs compared to control
(59.1% ± 2.4% versus 40.4% ± 4.1%, p < 0.05, unpaired t test;
Figure 3E).Weconfirmed this finding throughco-immunolabeling
of a mitochondrial marker (ATP5b) and an ER marker (Protein di-
sulfide isomerase [PDI]; data not shown). Further EM analysis re-
vealedan increase in thenumber of dilatedER inVCP-mutant d17
MNs compared to control (0.14 ± 0.004 versus 0.056 ± 0.00085,
p < 0.0001; unpaired t test; Figure 3F). Interestingly, we found no
clear evidence of transcriptional activation of the unfolded pro-
tein response, heat shock proteins, or chaperonin proteins (Fig-
ure S3A), which is consistent with the reported transient nature
of these responses (Lin et al., 2007). However, we found robust
transcriptional changes suggesting down-regulation of protein
translation, consistent with our aforementioned evidence of
VCP-mutation-dependent ER stress inducing a cytoprotective
translational arrest in d3 MNs (Figures S3B and S3C). Collec-
tively, these data suggest elevated ER stress in the VCP-mutant
MNs as an early phenotype detectable in d3 MNs.
on survival of MNs. The survival plot is presentedwith time in hours on the horizontal axis and the cumulative risk expressed as a logarithm on the vertical axis. The
cumulative hazard ratio value is presented in non-logarithmic form, and is based on the control MNs, posed as 1.
(C) (Ci) Representative confocal images showing apoptotic (full arrows) and pyknotic (empty arrows) cells at d17 of terminal differentiation. Scale bar: 25 mm. (Cii)
Proportion of cells positive for cleaved caspase 3 (top) or with nuclear pyknosis (bottom) over total number of cells. Data are expressed as mean ± SD, **p < 0.01;
unpaired t test.
(D) Analysis of synaptic puncta in hiPSC-MNs with or without VCP mutations. (Di) Images of single planes taken by confocal microscopy, showing presynaptic
synaptic marker SYT-1 (green) adjacent to the membrane of MNs (ChAT in blue) with intact nuclei (DAPI is white). (Dii) Graphs represent mean synapse density
values defined by puncta per surface area on the MN soma and dendrites (N = 51-56 cells or dendrites).
(E) (Ei) Images of a single confocal plane, demonstrating pre- and post-synaptic puncta labeled by SYT-1 and Homer-1 immunofluorescence, respectively. (Eii)
Graphs demonstrating synaptic densities defined by proximity analysis of SYT-1 and Homer-1 positive puncta and expressed as mean number of closely
adjacent puncta/cell surface area on the soma or dendrites (N = 28-30 cells or dendrites). Data represent mean ± SD. Taken together, the synaptic data in this
figure were generated from 3 control lines and 3 mutant-VCP lines, each of which was technically triplicated. ***p < 0.001, ****p < 0.0001, unpaired t test. Scale
Bar: 25 mm. NPC = neural precursor cells, MNs = motor neurons, d3 or d17 = after 3 or 17 days of terminal differentiation.
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Figure 3. TDP-43 Mislocalization and Endoplasmic Reticulum Stress Are Early Molecular Events in VCP-Mutant Motor Neurons
(A) (Ai) Immunofluorescence of control and VCP-mutant NPCs and d3 MN (blue, Hoechst; red, TDP-43). (Aii) Quantification of percentage of nuclear or cytosolic
TDP-43 positive area, normalized to total TDP-43 positive area in d3 MNs (n = 3 control lines and 4 VCP-mutant lines. p < 0.05, unpaired t test;R 2000 analyzed
per line, each in technical triplicate).
(B) (Bi and Bii) western blot images and quantification of BiP, phospho-eIF2alpha, total eIF2alpha, and b-actin levels in control and VCP-mutant NPCs, d3 MNs
and d17MNs (n = 3 control and 3mutant clones, from at least three independent cultures per line each in technical triplicate, *p < 0.05, **p < 0.01, unpaired t test).
(legend continued on next page)
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VCP-Mutant MNs Exhibit Decreased Mitochondrial
Membrane Potential and Evidence of Oxidative
Stress
Mitochondrial membrane potential (Dcm) was examined using
the fluorescent cationic dye TMRM (tetramethylrhodamine
methyl ester) (Figure S4A). VCP-mutant MNs exhibited signifi-
cantly lower Dcm at d17 (54.7% ± 6.6% versus 100%, p <
0.05, unpaired t test; Figure S4A). We examined the response
of Dcm to the complex V and I inhibitors oligomycin and rote-
none, respectively. Inhibition of complex I by rotenone produced
a rapid loss of Dcm (Figure S4B), while inhibition of complex V
had little effect, confirming intact respiration maintained Dcm in
both control and VCP-mutant MNs. These findings are consis-
tent with uncoupling of oxidative phosphorylation in VCP-mutant
MNs as previously reported in other model systems (Bartolome
et al., 2013). We next studied the balance of reactive oxygen
species (ROS) generation and levels of endogenous antioxidant
as a measure of oxidative stress. We assessed superoxide pro-
duction by measuring the rate of oxidation of the dihydroethi-
dium dye (DHE) as a ratio of the oxidized over the reduced
form (Figure S4Ci). We found that the VCP-mutant d3 MNs and
d17 MNs exhibited significantly higher rates of ROS production
compared to control (d3 MN 189.9% ± 30.4%, d17MNs
187.3% ± 42.7%; p < 0.05, unpaired t test; Figure S4Cii). Further-
more, a significant decrease in glutathione levels was identified
in the VCP-mutant d17 MNs only (50.16% ± 8.0% versus
100% control, p < 0.001, unpaired t test; Figure S4D). Together,
these data suggest an early increase in ROS generation in MNs,
but this is only associated with oxidative stress due to depletion
of glutathione levels in d17 MNs.
Autonomous and Non-autonomous Effects of
VCP-Mutant ACs in MN Degeneration
We next evaluated the contribution of VCP-mutant ACs in our
model. Using cross-sectional end point analysis, we found
no significant difference in survival between control and
VCP-mutant ACs (glial precursor cells [GPCs], d14 ACs and
d28ACs, p > 0.05, unpaired t test; data not shown). However,
recognizing the proliferative capacity of ACs in their differenti-
ated state, we reasoned that this might allow an underlying
survival phenotype to escape detection when using a cross-
sectional approach. Therefore, we again employed the more
sensitive real-time longitudinal-imaging platform and indeed
detected a significant increase in risk of cell death of the VCP-
mutant ACs compared to control ACs (Figure 4Ai). It is note-
worthy that the overall cumulative hazard ratio was lower for
ACs (both control and mutant) than that seen in MN cultures.
We investigated if the same sequence of molecular events
occurring in VCP-mutant MNs was also responsible for AC
death. Notably, there was no increased vulnerability of GPCs,
d14 ACs, or d28 ACs to an ER stressor, tunicamycin, when
comparing VCP-mutant to control cultures (Figure S4E). A tran-
sient decrease in the Dcm was observed in d14 VCP-mutant
ACs compared to controls (72.47% ± 2.09% versus 100%, p <
0.05, unpaired t test; Figure S4F). There was a transient signifi-
cant increase in the production of ROS in the VCP-mutant
GPCs versus control GPCs (p<0.05, unpaired t test; FigureS4G),
with no significant difference in glutathione levels in the control
versus mutant AC lineage (Figure S4H). Taken together, our find-
ings suggest only transient changes in mitochondrial health and
ROS production, but, overall, mutant ACs at least partially differ
from MNs in their underlying molecular phenotypes.
We then addressed if the VCP-mutant MN survival phenotype
could be rescued by co-culture with control ACs. Using cross-
sectional end-point analysis, we found that control ACs were
indeed able to ameliorate the survival phenotype of VCP-mutant
MNs in co-culture (76.9% ± 6.9% in VCP-mutant MNs alone,
23.6% ± 6.5% in control MNs alone, 21.9% ± 3.9% in VCP-mu-
tant MNs co-cultured with control ACs, *p < 0.05, **p < 0.01; un-
paired t test, Figures 4Bi and 4Bii). We next questioned if the VCP
mutation perturbed this ability of ACs to promote neuronal survival
in co-culture, indicating a potential non-cell-autonomous mecha-
nism of injury in VCP-related MN death. To systematically and
robustly address this, we again employed the sensitive automated
longitudinal-imaging method. Using this approach, we could
demonstrate that VCP-mutant ACswere less able to promote sur-
vival of both control and VCP-mutant MNs compared to control
ACs (Figures 4Ci and 4Cii). These data collectively suggest
VCP-mutation-related, non-cell-autonomous, AC-mediated ef-
fects through failure to support MNs. We further evaluated this
by direct comparison of both VCP-mutant and control MNs in
isolation and together in co-culture with either VCP-mutant or
control ACs. We show that VCP-mutant MN survival is increased
by co-culture with control ACs, while VCP-mutant ACs have a
comparably reduced capacity to support VCP-mutant MN sur-
vival (Figures 4Di and 4Dii). Furthermore, when the same compar-
ison is performed on control MNs, co-culture with control ACs
clearly improvesMN survival as expected. However, VCP-mutant
ACs fail to improve survival of control MNs to the same degree as
control ACs (Figures 4Di and 4Dii). These data indicate that co-
culturewithACs normally supports survival ofMNs, and that these
support mechanisms are disrupted by the VCP mutation in ACs.
DISCUSSION
In this study, we were able to optimize robust directed differen-
tiation of iPSCs into enriched spinal cord MN and AC cultures,
(C) Histogram showing thapsigargin induced calcium signal measured in calcium free media (n = 3 control and 3 mutant clones, *p < 0.05, unpaired t test).
(D) Histogram showing percentage of PI positive cells in control and VCP-mutant NPCs and d3MNswith or without 48 hr treatment with ER stressor tunicamycin,
n = 2 control lines and 3 mutant lines, p < 0.05, unpaired t test, > 50,000 cells per condition. Error bars represent mean ± SEM.
(E) Representative EM images and quantification of mitochondria-ER contacts in control and VCP-mutant d17MNs (n = 2 control lines and 3mutant lines; n = 762
for control mitochondria and n = 1708 for VCP-mutant mitochondria; p < 0.05, unpaired t test,). Yellow asterisks show mitochondrial in contact with the ER
(arrows). ER, endoplasmic reticulum; m, mitochondria.
(F) Representative EM images and quantification of maximum distance between opposing parallel ER membranes (mean ± SD 0.056 ± 0.0009 in control versus
0.140 ± 0.0041 in VCP-mutant, n = 375 ER from control and 463 ER from VCP mutant; p < 0.0001, unpaired t test). Yellow asterisks indicate dilated ER (arrows).
ER, endoplasmic reticulum; m, mitochondria. NPC = neural precursor cells, MNs = motor neurons, d3 or d17 = after 3 or 17 days of terminal differentiation.
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which we comprehensively validated at transcriptional and func-
tional levels in a stage specific manner. These efficient differen-
tiation strategies in turn permitted a range of careful cellular
and molecular phenotyping assays to systematically identify
the early VCP-mutation-dependent and cell-type-specific phe-
notypes.While no differential vulnerability was detected at earlier
stages of MN lineage restriction, we identified a robust pheno-
type within three days of terminal differentiation into MNs. Early
cytoplasmic mislocalization of TDP-43 and ER stress are later
followed bymitochondrial dysfunction, oxidative stress, reduced
synaptic density, and cell death. Furthermore, by harnessing the
sensitive longitudinal automatedmicroscopy approach, wewere
able to additionally show a VCP-mutation-dependent survival
phenotype in ACs. Using an iterative co-culture paradigm, we
then provide evidence of AC-mediated non-cell-autonomous
mechanisms of disease in VCP-mutation-related MN degenera-
tion. Taken together, our findings suggest that the VCP mutation
results in significant and progressive cell-autonomous MN pa-
thology, which is exacerbated by an impaired AC-supportive
capacity.
Cytoplasmic aggregates of TDP-43 are known to induce ER
stress in ALS, while ER stress itself has also been proposed to
drive cytoplasmicTDP-43mislocalization (Walker et al., 2013;Sa-
saki, 2010). Increased mitochondrial-ER contacts occurred as
secondary events in the VCP-mutant MNs, providing a possible
explanation of how our primary phenotypes (TDP-43mislocaliza-
tionandERstress) canbemechanistically linked toour secondary
phenotypes: cytosolic TDP-43 generates ER stress, which next
triggers increased tethering of the ER to mitochondria. In turn,
this may induce mitochondrial depolarization, alterations in mito-
chondrial calciumandoxidative stress. Indeed, the latter is awell-
recognized feature of both sporadic and familial forms of ALS
(Ilieva et al., 2007; Kiskinis et al., 2014). The presence of oxidative
stress in ourmodelmay further compoundERstressby leading to
proteosomal failure (Sitte et al., 2000). Chronic ER stress in turn
can lead tocell deathbymitochondria-dependent or independent
mechanisms (Lindholm et al., 2006). Our finding of a mutation-
dependent reduction in synapse density could represent pertur-
bation of pre-synaptic MN terminals, MN autosynapses, or IN
interactions. These datamayalso reflect post-synaptic pathology
inMNs.Accumulatingevidence implicatesearly synaptic lossand
a relative increase in glutaminergic synaptic activity, which could
potentially lead to MN dysfunction by excitotoxicity-independent
mechanisms (Ilievaet al., 2007). Previousstudieshave shown that
increased glutamatergic activity-induced calcium influx results in
ER stress and increased mitochondrial calcium uptake, depolar-
ization, and ROS production, thus feeding into a vicious cycle
(Shaw et al., 1995; Howland et al., 2002), which is consistent
with our findings.
In the wider ALS landscape, the SOD1 (superoxide dismutase
1) mutation has been shown to cause a cell-autonomous survival
phenotype in hiPSC-derived MNs (Kiskinis et al., 2014). The
presence of a SOD1-mutation-dependent cell autonomous AC
phenotype has yet to be systematically addressed. SOD1-
mutant ACs, however, are known to exhibit a non-cell-autono-
mous phenotype, adversely affecting MNs (Di Giorgio et al.,
2008). A similar effect has also been reported in sporadic ALS
ACs (Haidet-Phillips et al., 2011). Conversely, a cell-autonomous
astrocytopathy — in the absence of non-cell-autonomous ef-
fects — has been reported in the context of TARDBP mutations
(Serio et al., 2013). It is noteworthy that our experiments uncover
both a cell-autonomous and non-cell-autonomous role for ACs
in the context of VCP mutations, therefore possibly suggesting
divergent and mutation-specific glial contributions in ALS path-
ogenesis. Our co-culture results (specifically VCP-mutant ACs
with control MNs; Figure 4Di) would indicate that non-cell-auton-
omous effects are largely attributable to impaired supportive
capacity of VCP-mutant ACs.
Figure 4. VCP-Mutant Astrocyte Cell-Autonomous and Non-Cell-Autonomous Phenotypes
(A) Longitudinal-imaging-based survival analysis comparing VCP-mutant versus CTRL ACs. (Ai) Representative images showing two ACs captured by longi-
tudinal imaging when both alive (left panel, full arrows) and after one died (empty arrow) at a later time point (right panel). (Aii) VCP-mutant ACs show increased
cumulative risk of death under basal conditions (cumulative hazard ratio [cHR] = 1.5, p = 4.53 104; CTRL ACs taken as baseline). N = 3 control lines and 3mutant
lines. To estimate survival Kaplan–Meier and cumulative risk-of-death curves were plotted using R, while Cox proportional hazards analysis, also calculated in R,
was used to determine the influence of the VCP mutation on the survival of ACs. The survival plot is presented with time in hours on the horizontal axis and the
cumulative risk expressed as a logarithm on the vertical axis. The cumulative hazard ratio value is presented in non-logarithmic form, and is based on the control
ACs, posed as 1.
(B) MN death analysis in MN-AC co-cultures. (Bi) Representative images showing cultures of control or VCP-mutant MNs alone, or VCP-mutant MNs cultured
on control ACs. Hoechst: nuclear. Live/dead green: dead cells. Islet1: MN marker. GFAP: astrocyte marker. (Bii) Quantification of % dead islet1 positive cells,
p < 0.01; unpaired t test. Error bars represent mean ± SEM.
(C) (Ci) Longitudinal imaging based survival analysis of different MNs and ACs co-cultures from both VCP and control lines. VCP-mutant MNs present a
significantly decreased survival compared to all other culture conditions when co-cultured with VCP ACs (dashed red line). Co-cultures of control and VCP cells in
any combination present a less severe, but still significantly increased, survival deficit (dashed blue line and solid red line), compared with a co-culture of control
MNs and ACs (solid blue line). (Cii) Graph showing the cHR of the different co-culture paradigms, compared to survival of control MNs on control ACs set at 1
(dashed line). cHR values are: CTRL MNs on VCP-mutant ACs = 1.43, p = 3.83 106; VCP-mutant MNs on CTRL ACs = 1.48, p = 5.323 107; VCP-mutant MNs
on VCP-mutant ACs = 2.13, p < 2 3 1016.
(D) (Di) Comparison of control (left) and VCP-mutant (right) MN survival across the different culture conditions to elucidate non-cell autonomous effect of ACs on
MN survival. (Dii) Graph showing the cHR of all groups compared to survival of the sameMNswhen co-culturedwith control ACs set at 1 (dashed line). cHR values
are: CTRLMNs on VCP-mutant ACs = 1.57, p = 3.33 108; CTRLMNs alone = 1.77, p = 6.03 109; VCP-mutant MNs on CTRL ACs = 1.58, p = 3.23 109; VCP-
mutant MNs on VCP-mutant ACs = 2.03, p < 23 1016; VCP-mutant MNs one = 3.00, p < 23 1016; n = 3 control lines and 3 mutant lines for MN and 2 control
lines and 2 mutant lines for ACs. To estimate survival Kaplan–Meier and cumulative risk-of-death curves were plotted using R, while Cox proportional hazards
analysis, also calculated in R, was used to determine the influence of VCP and co-culture conditions on survival of MNs and ACs. All survival plots are presented
with time in hours at the horizontal axis and the cumulative risk expressed as a logarithm at the vertical axis. The cumulative hazard ratio values are presented in
non-logarithmic form, and are all based on the relevant control for that particular experiment, posed as 1. MNs = motor neurons, ACs = astrocytes.
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In summary, our study demonstrates the potential of inte-
grating directed differentiation of iPSCs with time-resolved phe-
notyping assays as a pre-clinical model to confidently identify
primary molecular pathogenic events in ALS patient-derived
MNs, together with cell autonomous and non-cell-autonomous
contributions of mutant ACs in this context. Our findings
could thus help drive the development of therapies addressing
specific disease-initiating mechanisms and raise the prospect
of targeting ACs as a strategy to ameliorate disease progression
in ALS.
EXPERIMENTAL PROCEDURES
Ethics Statement
Informed consent was obtained from all patients and healthy controls in this
study. Experimental protocols were all carried out according to approved
regulations and guidelines by UCLH’s National Hospital for Neurology and
Neurosurgery and UCL’s Institute of Neurology joint research ethics commit-
tee (09/0272).
Derivation of Human Fibroblasts and iPSC Generation
Informed consent was obtained from all patients prior to skin biopsy. Dermal
fibroblasts were cultured in OptiMEM +10% FCS medium. The following
episomal plasmids were transfected for iPSC generation: pCXLE hOct4
shp53, pCXLE hSK, and pCXLE hUL (Addgene), as previously reported (Okita
et al., 2011). Details of the lines used in thus study are provided in Table S1.
Two of the control lines used (control 2 and control 3) are commercially avail-
able and were purchased from Coriell (cat. number ND41866*C) and Thermo-
Fisher Scientific (cat. number A18945) respectively.
Cell Culture
Induced PSCs were maintained on Geltrex (Life Technologies) with Essential 8
Medium media (Life Technologies), and passaged using EDTA (Life Technolo-
gies, 0.5mM). All cell cultures weremaintained at 37Cand 5%carbon dioxide.
Statistical Analysis
For any experiment, the average experimental unit is calculated, then the
average across all the clones is taken, so the variation shown is the biological
variation across biological replicates (n = 3 control clones, n = 4 mutant
clones). The data are checked for normality, and we utilized an unpaired
t test with post hoc correction for multiple testing.
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